MARKET

XLO

XLO

Xilio Therapeutics, Inc.
NASDAQ
0.7100
-0.0100
-1.39%
After Hours: 0.7164 +0.0064 +0.90% 16:43 05/09 EDT
OPEN
0.7100
PREV CLOSE
0.7200
HIGH
0.7499
LOW
0.7000
VOLUME
143.90K
TURNOVER
--
52 WEEK HIGH
1.700
52 WEEK LOW
0.6200
MARKET CAP
36.76M
P/E (TTM)
-0.6523
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA), Galmed Pharmaceuticals (GLMD) and Xilio Therapeutics (XLO)
TipRanks · 2d ago
Xilio Therapeutics Q1 EPS $(0.18) Misses $0.10 Estimate, Sales $2.93M Miss $4.40M Estimate
Benzinga · 2d ago
*Xilio Therapeutics Cash and Cash Equivalents Were $89.1M as of March 31 >XLO
Dow Jones · 2d ago
Press Release: Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2025 Financial Results
Dow Jones · 2d ago
Press Release: Xilio Therapeutics Announces -3-
Dow Jones · 2d ago
Weekly Report: what happened at XLO last week (0428-0502)?
Weekly Report · 5d ago
XILIO THERAPEUTICS ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 05/02 20:30
Weekly Report: what happened at XLO last week (0421-0425)?
Weekly Report · 04/28 09:24
More
About XLO
More
Xilio Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. It is using its proprietary platform to build a pipeline of novel, tumor-activated I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines, antibodies, bispecific and immune cell engagers. Its pipeline products include Vilastobart (XTX101), XTX301, XTX501, and tumor-activated bispecific molecules and immune cell-engaging molecules. XTX101 is an investigational tumor-activated, Fc-enhanced, high-affinity binding anti-CTLA-4 monoclonal antibody. XTX301, a tumor-activated, engineered interleukin 12, or IL-12, therapy.
Recently
Symbol
Price
%Change
    XLO
  • 0.7100
  • -1.39%

Webull offers Xilio Therapeutics Inc stock information, including NASDAQ: XLO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XLO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XLO stock methods without spending real money on the virtual paper trading platform.